VANCOUVER, Jan. 17, 2019 /CNW/ - INVICTUS MD STRATEGIES
CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA:
8IS1) is pleased to announce that George E. Kveton,
President and CEO of Invictus, and Paul
Sparkes, Chairman of Invictus, will attend CannaTech at the
World Economic Forum in Davos,
Switzerland for a panel discussion entitled How to Build
International Brands in the Cannabis Industry on Wednesday, January 23, 2019 at 4:00 p.m. GMT. Invicuts will present alongside
top international cannabis industry leaders including Bruce Linton, CEO of Canopy Growth Corporation
("Canopy Growth").
CannaTech, to be held January 22-25,
2019, is widely recognized as the premier cannabis event. It
is the only event of its kind with a truly global focus that offers
senior industry leaders, medical and scientific experts, and new
ventures the platform to come together, drive innovation, form
partnerships and promote knowledge exchange. CannaTech will feature
dynamic presentations that focus on science, research, finance,
medicine, tech, agriculture, innovation and government policy.
"Right now, we are witnessing a global shift in the discussion
around cannabis and its impact on the future of medicine and adult
recreational enjoyment," said George E. Kveton, President and CEO
of Invictus. "By hosting a cannabis summit in concert with World
Economic Forum, CannTech provides an incredible opportunity to
share the Invictus story with the world's top economic and
political leaders."
Paul Sparkes, Chairman of
Invictus added. "It is an honour to represent Invictus on the
international stage at this critical time of growth in our
industry," said Paul Sparkes,
Chairman of Invictus. "As we look to new markets to build
partnerships in business, we also find value in sharing experiences
from legalization of recreational cannabis in Canada so that we may work together to build a
strong, successful global industry that benefits patients and
consumers alike."
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
George E. Kveton
Chief Executive Officer and Director
Jessica Martin
Vice President, Public Relations and Regulatory Affairs
(833) 879-4363
About Invictus
Invictus is a global cannabis company offering a selection of
products under a wide range of brands. Our integrated sales
approach is defined by five pillars of distribution including
medical, adult-use, international, Licensed Producer to Licensed
Producer and retail stores.
Invictus has partnered with business leaders to convey our
corporate vision, including KISS music legend and business mogul
Gene Simmons as our Chief Evangelist
Officer. To meet growing demand, Invictus is expanding its
cultivation footprint, with three cannabis production facilities
licensed under the Cannabis Act and Cannabis Regulations in
Canada. To accommodate
international sales, Invictus' wholly-owned subsidiary, Acreage
Pharms Ltd. ("Acreage Pharms"), has designed and is currently
building its Phase 3 purpose-built cultivation facility to be
European Union Good Manufacturing Practices ("EU-GMP") compliant.
The Company is targeting up to 50 percent of production to medical
cannabis. To ensure consistency in quality and supply, Invictus
maintains all aspects of the growing process through its
subsidiary, Future Harvest Development Ltd. ("Future Harvest"), a
high-quality fertilizer and nutrients manufacturer. Invictus drives
sustainable long-term shareholder value through a diversified
product portfolio with over 70 Health Canada approved strains and a
multifaceted distribution strategy including medical, adult-use,
international, Licensed Producer to Licensed Producer and retail
stores. For more information visit www.invictus-md.com.
Neither the Canadian Securities Exchange nor its Regulation
Services Provider accepts responsibility for the adequacy or
accuracy of this release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/invictus-executives-to-represent-cannabis-at-world-economic-forum-in-davos-switzerland-january-23-at-4pm-gmt-300780882.html
SOURCE Invictus MD Strategies